All episodes
The Pharmacology of Study Drugs: Amphetamines, Dopamine, and Cognitive Enhancement
Withdrawal or Relapse? Why Antidepressant Discontinuation Can Be Misunderstood
When Addiction Treatment Becomes Addiction Maintenance: The Pharmacology Behind Rehab Fraud
SSRIs Compared: Best Diagnoses, Half-Lives, Side Effects, and Prescribing Exceptions
Dopamine Blockade: Why Antipsychotics Work and Why They Cause Side Effects
Why Prozac, Zoloft, and Lexapro Affect Patients Differently
Why Antidepressants Take Weeks to Work
Methamphetamine vs. Adderall: How Different Are They Really?
Why Antidepressants Take Weeks to Work
Beyond Fentanyl: The Rise of Synthetic Opioids Ten Times More Potent
Why Antidepressants Sometimes Stop Working: The Science Behind the Loss of Response
When Antipsychotics Aren’t the Answer: The Medical Illness That Can Look Like Psychosis
Why Do SSRIs Take Weeks to Work If They Change Serotonin Within Hours?
Beyond the Daily Pill: The Injection Shaking Up Bipolar Treatment
A Simpler Way to Ease OCD When Bipolar Is Also in the Picture
The FDA Is Fast-Tracking Psychedelics. Noribogaine Is the Test Case That Is Not a Trip.
Know Your Brain: The Four Lobes and What They Actually Do
Psychopharmacology Masterclass: Drug Classes, Mechanisms of Action, and What Every Psychologist Needs to Know for Clinical Practice and the
Retracted: The Hepatitis B Vaccine, Autism Claims, and the Challenges of Causation
Escitalopram for Kids’ Anxiety: FDA Approval or Risky Gamble? Weighing the Evidence”
Noribogaine (DMX-1001): A Neuroplastogen Breakthrough for Alcohol Use Disorder or Another Psychedelic Promise with Risks?
Rising Costs in Healthcare: The 2026 Pharmaceutical Price Increases and Their Implications
The Accidental Mind: Serendipity and the Birth of Modern Psychopharmacology part 2
The Accidental Mind: Serendipity and the Birth of Modern Psychopharmacology part 1
Curcumin: Turmeric’s Golden Promise for Blood Sugar and Mood – Evidence, Arguments For and Against
Dextromethorphan ( think cough syrup) for OCD: A Promising Glutamate-Targeted Augmentation Strategy?
Antidepressants and Suicide Prevention: Lessons from Korea’s 2002 Prescription Restrictions
Silent Slip: How Medications Are Fueling Falls in Our Elderly
The Dangerous Tetrad: Mastering the Fatal Signs of Rigidity and Fever -case study
Antidepressant Withdrawal: 50% of Long-Term Users Suffer? Shocking JAMA Study vs Real-World Reality Exposed
Metabolic Brake or Muscle Catalyst? The Pharmacokinetics of GLP-1 Muscle Loss
Ibogaine: Miracle Cure or Medical Gamble? The Truth Behind a Controversial Psychedelic
Low-Dose Methamphetamine Neuroprotection: What the Studies Actually Show
The Messy Truth About Antidepressants: Benefits, Risks, and the Limits of the Evidence
Why One ADHD Medication Hits Kids So Differently — And How Genetics Can Help
Artificial intelligence begins prescribing medications in Utah
Marijuana and emphysema
Ketamine and neurotoxicity
New study on lithium
Is low-dose quetiapine safe for insomnia?
How assessments can increase antidepressant prescriptions
Saffron being studied for insomnia
Centanafadine is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) under development for ADHD.
IS THERE A DIFFERENCE BETWEEN THE INJECTABLE OR ORAL NALTREXONE AND TREATMENT
A LOOK AT BIRTH CONTROL TO DEPRESSION TO ANTIDEPRESSANTS
PRAMIPEXOLE FOR TREATMENT RESISTANT DEPRESSION
ABILIFY COULD LEAD TO GAMBLING ADDICTION
VARENICLINE POSSIBLY COULD HELP WITH ALCOHOL USE DISORDER
ANTIDEPRESSANTS DURING PREGNANCY MAY ALTER FETAL DEVELOPMENT
LEVETIRACETAM POSSIBLE ADJUNCT FOR BIPOLAR MANIA
A STUDY ON ANTIPSYCHOTICS
TOM WOLF DISCUSSES HIS OVERCOMING OF ADDICTION AND HOMELESSNESS
PSILOCYBIN USE SKYROCKETS
A POSSIBLE NEW TREATMENT FOR SCHIZOPHRENIA
ATOMOXETINE, AMPHETAMINES FOR SCHIZOPHRENIA STUDY
HOW SSRI MIGHT AFFECT HEART DEVELOPMENT
ANTIPSYCHOTICS HELPS WITH CANNABIS INDUCED PSYCHOSIS
CLOZAPINE AND HYPERSALIVATION
PIMAVANSERIN DOES IT HELP WITH SCHIZOPHRENIA AND NEGATIVE SYMPTOMS
CANNABIS AND HEART DISEASE
DR. MONCRIEFF HER NEW BOOK CHEMICALLY IMBALANCED
A BRIEF LOOK AT SOME NEW PSYCHEDELIC RESEARCH
WEIGHT LOSS DRUGS CAN HELP YOUR HEALTH IN MANY WAYS BUT THERE ARE CONCERNS
NEW ANTI-PSYCHOTIC FOR SCHIZOPHRENIA
WE LOOK AT ANTIPSYCHOTIC SIDE EFFECTS
A STUDY ON ANTIPSYCHOTICS
WE CHAT WITH DR. ARMSTRONG ABOUT PSYCHEDELICS
DR. GOMINAK DISCUSSES THE IMPORTANCE OF VITAMIN D AND SLEEP
LITHIUM COULD PREVENT HOSPITALIZATION
FDA REJECTS MDMA
CAN OZEMPIC HELP WITH ADDICTION
TOM WOLF DISCUSSES HIS OVERCOMING OF ADDICTION AND HOMELESSNESS AND WHAT TO DO ABOUT IT3
STUDY LOOKS AT MAINTENANCE OPIOID THERAPY BUPRENORPHINE
IS LITHIUM EFFECTIVE IN REDUCING SUICIDE COMPLETIONS
STUDY SHOWS OZEMPIC LINKED TO POTENTIAL VISION LOSS
EVOLUTIONARY PSYCHIATRY WITH DR.NESSE
SSRI'S STUDY SHOWS CORRELATION WITH STRESS CARDIOMYOPATHY
ESCITALOPRAM AND TREATMENT EMERGENT AFFECTIVE SWITCH
KETAMINE TABLETS SHOW PROMISE FOR TREATING SEVERE DEPRESSION
IBOGAINE AND PTSD
PSILOCYBIN VS ESCITALOPRAM WITH MAJOR DEPRESSION AND GENERALIZED ANXIETY
ADHD MEDS AND $100 MILLION FRAUD ARREST3
CELECOXIB AND POSTPARTUM DEPRESSION STUDY
FDA REJECTS MDMA FOR PTSD
STUDY ON SSRI'S AND OCD
A STUDY ON CLONIDINE AND TOURETTE SYNDROME COMORBID ADHD
ASTRA ZENECA REMOVES COVID VACCINE AFTER RARE SIDE EFFECT IS LINKED TO 80 DEATHS
L-THEANINE ADJUNCT TO SERTRALINE FOR MAJOR DEPRESSIVE DISORDER
TESTING AN OPIOID MEDICATION WITH BUILT IN PROTECTION
BUPRENORPHINE NOW CAN BE OBTAINED VIA TELEHEALTH AND MORE
WE CHATTED WITH DR. POPE ABOUT ANABOLIC STEROIDS
DR. JOSEPH DISCUSSES THE LIMITATIONS OF GENETIC STUDIES
PAXLOVID AND COVID 19 STUDY
A COMBINATION OF TWO MEDICATIONS SHOW PROMISE IN HELPING WITH ALCOHOL USE DISORDER
PRENATAL CANNABIS USE AND INCREASED RISK FOR ADHD AND AUTISM SPECTRUM DISORDER
RISK OF AUTISM AFTER PRENATAL EXPOSURE TO VALPROATE
METH RELATED CARDIO MYOPATHY
ACCIDENTAL EXPOSURE TO FENTANYL PATCHES CONTINUE TO BE DEADLY TO CHILDREN
AN INTERESTING STUDY ON PROTON PUMP INHIBITORS AND PULMONARY TB
DR. HASKINS DISCUSSES FRAUD IN THE MEDICAL FIELD1